CTOs on the Move

Mount Nittany Medical Center

www.mountnittany.org

 
Mount Nittany Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in State College, PA. To find more information about Mount Nittany Medical Center, please visit www.mountnittany.org
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Larry Rogers
Chief Information Officer Profile
Doug Carroll
Chief Information Security Officer Profile

Similar Companies

I D Medical Systems Inc

I D Medical Systems Inc is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patheous Health

Patheous Health is a company that specializes in dysphagia healthcare and swallowing impairment conditions. They offer an Integrated Dysphagia Healthcare (iDH) platform and provide service solutions for both MBS and FEES studies.

Nebraska Heart Institute

Nebraska Heart Institute is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Center at Franklin

Medical Center at Franklin is a Franklin, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.